MiMedx Group, Inc. (MDXG) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 1.50M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 15.71M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 281.00M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $1.50M | $15.71M | (m) | (m) | $281.00M | (m) |
| 2026-03-31 | (m) | (m) | $1.50M | $16.09M | (m) | (m) | $308.68M | (m) |
| 2025-12-31 | (m) | (m) | $1.50M | $16.47M | (m) | (m) | $342.65M | (m) |
| 2025-09-30 | (m) | (m) | $1.38M | $16.84M | (m) | (m) | $318.99M | (m) |
| 2025-06-30 | (m) | (m) | $1.25M | $17.21M | (m) | (m) | $291.11M | (m) |
| 2025-03-31 | (m) | (m) | $1.13M | $17.53M | (m) | (m) | $270.42M | (m) |
| 2024-12-31 | (m) | (m) | $1.00M | $17.83M | (m) | (m) | $263.92M | (m) |
| 2024-09-30 | (m) | (m) | $1.00M | $18.02M | (m) | (m) | $243.89M | (m) |
| 2024-06-30 | (m) | (m) | $1.00M | $18.25M | (m) | (m) | $230.18M | (m) |
| 2024-03-31 | (m) | (m) | $1.00M | $18.45M | (m) | (m) | $221.68M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $48.10M | (m) | (m) | $239.05M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $48.97M | (m) | (m) | $189.02M | (m) |
| 2023-06-30 | (m) | (m) | (m) | $48.84M | (m) | (m) | $176.38M | (m) |
| 2023-03-31 | (m) | (m) | (m) | $48.71M | (m) | (m) | $168.16M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $48.59M | (m) | (m) | $171.43M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $48.48M | (m) | (m) | $172.80M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $48.36M | (m) | (m) | $168.67M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $48.24M | (m) | (m) | $174.44M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $48.13M | (m) | (m) | $187.93M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $48.02M | (m) | (m) | $180.52M | (m) |
| 2021-06-30 | (m) | (m) | (m) | $47.91M | (m) | (m) | $187.15M | (m) |
| 2021-03-31 | (m) | (m) | (m) | $47.80M | (m) | (m) | $190.81M | (m) |
| 2020-12-31 | (m) | (m) | $0.00 | $47.70M | (m) | (m) | $202.03M | (m) |
| 2020-09-30 | (m) | (m) | $0.00 | $47.63M | (m) | (m) | $213.32M | (m) |
| 2020-06-30 | (m) | (m) | $3.75M | $61.47M | (m) | (m) | $150.91M | (m) |
| 2020-03-31 | (m) | (m) | $3.75M | $61.64M | (m) | (m) | $158.91M | (m) |
| 2019-12-31 | (m) | (m) | $3.75M | $61.91M | (m) | (m) | $167.17M | (m) |
| 2019-09-30 | (m) | (m) | $3.75M | $62.17M | (m) | (m) | $179.27M | (m) |
| 2019-06-30 | (m) | (m) | $3.75M | $63.07M | (m) | (m) | $170.31M | (m) |
| 2018-12-31 | (m) | (m) | $0.00 | $0.00 | (m) | (m) | $122.84M | (m) |
| 2013-12-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | $84.69M | (m) |
| 2013-09-30 | (m) | (m) | (m) | $0.00 | (m) | (m) | $45.30M | (m) |
| 2013-06-30 | (m) | (m) | (m) | $0.00 | (m) | (m) | $40.28M | (m) |
| 2013-03-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | $37.85M | (m) |
| 2012-12-31 | (m) | (m) | $0.00 | $4.01M | (m) | (m) | $35.18M | (m) |
| 2011-12-31 | (m) | (m) | $1.13M | $2.74M | (m) | (m) | $27.10M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |